Skip to main content

Radiation Exposure Deriving from Patients Treated with 165Dy-Ferric Hydroxide

  • Conference paper
Radioactive Isotopes in Clinical Medicine and Research XXIII

Part of the book series: Advances in Pharmacological Sciences ((APS))

  • 100 Accesses

Abstract

In radiation synovectomy 1–10 GBq Dysprosium-165 ferric hydroxide is injected into the joints. To estimate the radiation exposure of persons in the neighbourhood of the patients measurements of the dose rates were performed in 5cm, 0.5m, lm and 2m distance of the surface of the treated joints (knees) until 200 min after the application. The highest doses were estimated for the fingers of the technologist (212μSv) and for the physician (550μSv). In order to reduce the doses we constructed special shieldings for the syrings. The whole body doses were 79 μSv for the technologist and 24 μSv for the physician. After the discharge to a ward or at home other persons in lm distance from the patients can receive 72 μSv, which is 4.8% of the permissible dose.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Hnatowich DJ, Kramer RI, Sledge CB, Noble J, Shortkoff S: Dysprosium-165 ferric hydroxide macroaggregates for radiation synovectomy. J Nucl Med 1977; 19: 303–308

    Google Scholar 

  2. Lederer CM, Shirley VS (eds.): Table of isotopes. Wiley & Sons, 7th ed. 1978

    Google Scholar 

  3. ICRP Publication 38: Radionuclide transformations. Pergamon Press 1983

    Google Scholar 

  4. Pirich C, Priifert U, Havlik E, Schwarmeis E, Flores J, Kvaternik H, Angelberger P, Aiginger H, Wanivenhaus A, Sinzinger H: Monitoring of the biodistribution and biokinetics of dysprosium-165 ferric hydroxide with a shadow-shield whole-body counter. Eur J Nucl Med 1997; 24: 398–402

    PubMed  CAS  Google Scholar 

  5. Basic Safety Standard 96/EURATOM

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer Basel AG

About this paper

Cite this paper

Havlik, E., Karanikas, G., Pirich, C., Preitfellner, J., Schaffarich, P., Sinzinger, H. (1999). Radiation Exposure Deriving from Patients Treated with 165Dy-Ferric Hydroxide. In: Bergmann, H., Köhn, H., Sinzinger, H. (eds) Radioactive Isotopes in Clinical Medicine and Research XXIII. Advances in Pharmacological Sciences. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-8782-3_46

Download citation

  • DOI: https://doi.org/10.1007/978-3-0348-8782-3_46

  • Publisher Name: Birkhäuser, Basel

  • Print ISBN: 978-3-0348-9772-3

  • Online ISBN: 978-3-0348-8782-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics